Consolidated Balance Sheet

OncoTherapy Science, Inc. - Filing #7300533

Concept As at
2024-09-30
As at
2024-03-31
Consolidated balance sheet
Balance sheet
Assets
Non-current assets
Investments and other assets
49,505,000 JPY
49,505,000 JPY
Investments and other assets
Non-current assets
49,505,000 JPY
49,505,000 JPY
Current assets
Cash and deposits
1,098,274,000 JPY
527,656,000 JPY
Accounts receivable - trade
44,059,000 JPY
35,621,000 JPY
Work in process
123,670,000 JPY
30,216,000 JPY
Raw materials and supplies
65,292,000 JPY
43,783,000 JPY
Advance payments to suppliers
28,116,000 JPY
9,102,000 JPY
Other
139,173,000 JPY
104,570,000 JPY
Current assets
1,498,587,000 JPY
817,769,000 JPY
Assets
1,548,092,000 JPY
867,275,000 JPY
Liabilities
Non-current liabilities
Non-current liabilities
126,148,000 JPY
154,015,000 JPY
Asset retirement obligations
47,225,000 JPY
47,165,000 JPY
Current liabilities
Accounts payable - other
203,447,000 JPY
139,436,000 JPY
Income taxes payable
74,210,000 JPY
2,425,000 JPY
Other
15,157,000 JPY
20,299,000 JPY
Current liabilities
421,595,000 JPY
359,593,000 JPY
Liabilities
547,743,000 JPY
513,608,000 JPY
Liabilities and net assets
Shareholders' equity
927,748,000 JPY
279,166,000 JPY
Share capital
647,141,000 JPY
50,000,000 JPY
Capital surplus
26,919,273,000 JPY
26,322,132,000 JPY
Retained earnings
-26,638,661,000 JPY
-26,092,962,000 JPY
Treasury shares
-3,000 JPY
-2,000 JPY
Share acquisition rights
72,600,000 JPY
74,500,000 JPY
Net assets
1,000,348,000 JPY
353,666,000 JPY
Liabilities and net assets
1,548,092,000 JPY
867,275,000 JPY
Net assets
Shareholders' equity

Talk to a Data Expert

Have a question? We'll get back to you promptly.